Global Artificial Intelligence Drug Development Market Growth (Status and Outlook) 2026-2032
The global Artificial Intelligence Drug Development market size is predicted to grow from US$ 3730 million in 2025 to US$ 14970 million in 2032; it is expected to grow at a CAGR of 22.2% from 2026 to 2032.
Artificial intelligence drug development refers to the use of AI technologies such as machine learning, deep learning, and big data analytics to accelerate drug discovery, design, and development processes. It spans multiple stages including target identification, molecule screening, and clinical trial optimization, significantly improving efficiency and reducing costs.
The upstream of the industry chain includes biological data resources such as genomic and protein structure data, computing infrastructure, and algorithm development capabilities. Downstream applications are concentrated in pharmaceutical companies, biotechnology firms, and contract research organizations. Pharmaceutical companies adopt AI to shorten development timelines, improve success rates, and reduce costs. Biotech firms leverage AI platforms for innovative drug design and technology commercialization, while CROs use AI to enhance clinical trial design and data analysis. With the growth of precision medicine and personalized therapies, AI applications are expanding in areas such as rare diseases, oncology, and complex conditions. Increasing collaboration between large pharmaceutical companies and AI firms is accelerating commercialization. Development trends include multi-modal data integration, the use of generative AI for molecular design, automated laboratories combining AI and robotics, and the development of end-to-end drug discovery platforms, moving toward platform-based ecosystems. Driving factors include high R&D costs, long development cycles, low success rates in traditional drug discovery, and technological advancements driven by data accumulation and computing power. Constraints include limitations in data quality and standardization, lack of model interpretability, regulatory uncertainties, and challenges in cross-disciplinary integration. Overall industry gross margins are relatively high, especially for platform and technology service providers, typically ranging from 40% to 70%, although significant upfront investment and long return cycles remain key challenges.
LPI (LP Information)' newest research report, the ?Artificial Intelligence Drug Development Industry Forecast? looks at past sales and reviews total world Artificial Intelligence Drug Development sales in 2025, providing a comprehensive analysis by region and market sector of projected Artificial Intelligence Drug Development sales for 2026 through 2032. With Artificial Intelligence Drug Development sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Artificial Intelligence Drug Development industry.
This Insight Report provides a comprehensive analysis of the global Artificial Intelligence Drug Development landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Artificial Intelligence Drug Development portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Artificial Intelligence Drug Development market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Artificial Intelligence Drug Development and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Artificial Intelligence Drug Development.
This report presents a comprehensive overview, market shares, and growth opportunities of Artificial Intelligence Drug Development market by product type, application, key players and key regions and countries.
Segmentation by Type:
Artificial intelligence drug development refers to the use of AI technologies such as machine learning, deep learning, and big data analytics to accelerate drug discovery, design, and development processes. It spans multiple stages including target identification, molecule screening, and clinical trial optimization, significantly improving efficiency and reducing costs.
The upstream of the industry chain includes biological data resources such as genomic and protein structure data, computing infrastructure, and algorithm development capabilities. Downstream applications are concentrated in pharmaceutical companies, biotechnology firms, and contract research organizations. Pharmaceutical companies adopt AI to shorten development timelines, improve success rates, and reduce costs. Biotech firms leverage AI platforms for innovative drug design and technology commercialization, while CROs use AI to enhance clinical trial design and data analysis. With the growth of precision medicine and personalized therapies, AI applications are expanding in areas such as rare diseases, oncology, and complex conditions. Increasing collaboration between large pharmaceutical companies and AI firms is accelerating commercialization. Development trends include multi-modal data integration, the use of generative AI for molecular design, automated laboratories combining AI and robotics, and the development of end-to-end drug discovery platforms, moving toward platform-based ecosystems. Driving factors include high R&D costs, long development cycles, low success rates in traditional drug discovery, and technological advancements driven by data accumulation and computing power. Constraints include limitations in data quality and standardization, lack of model interpretability, regulatory uncertainties, and challenges in cross-disciplinary integration. Overall industry gross margins are relatively high, especially for platform and technology service providers, typically ranging from 40% to 70%, although significant upfront investment and long return cycles remain key challenges.
LPI (LP Information)' newest research report, the ?Artificial Intelligence Drug Development Industry Forecast? looks at past sales and reviews total world Artificial Intelligence Drug Development sales in 2025, providing a comprehensive analysis by region and market sector of projected Artificial Intelligence Drug Development sales for 2026 through 2032. With Artificial Intelligence Drug Development sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Artificial Intelligence Drug Development industry.
This Insight Report provides a comprehensive analysis of the global Artificial Intelligence Drug Development landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Artificial Intelligence Drug Development portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Artificial Intelligence Drug Development market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Artificial Intelligence Drug Development and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Artificial Intelligence Drug Development.
This report presents a comprehensive overview, market shares, and growth opportunities of Artificial Intelligence Drug Development market by product type, application, key players and key regions and countries.
Segmentation by Type:
- Protein Structure Prediction
- Structure-Based Drug Design
- Ligand-Based Drug Design
- Generative AI Molecular Design
- Multi-Omics Integrated Analysis
- ADMET Property Prediction
- Knowledge Graph Drug Repurposing
- Billion-Level Parameters
- Ten-Billion-Level Parameters
- Hundred-Billion-Level Parameters
- Trillion-Level Parameters
- Small Molecule Drugs
- Antibody Drugs
- Peptide Drugs
- Nucleic Acid Drugs
- Vaccines
- Synthetic Biology Drugs
- Oncology Therapeutics
- Infectious Disease Drugs
- Neurological Disorder Drugs
- Cardiovascular Disease Drugs
- Rare Disease Drugs
- Autoimmune Disease Drugs
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Insilico Medicine
- Schr?dinger
- Recursion
- BenevolentAI
- Owkin
- Valo Health
- XtalPi
- Standigm
- Evaxion Biotech
- AbCellera
- Absci
- Iktos
- BioMap
- Genialis
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Artificial Intelligence Drug Development Market Size (2021-2032)
2.1.2 Artificial Intelligence Drug Development Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Artificial Intelligence Drug Development by Country/Region (2021, 2025 & 2032)
2.2 Artificial Intelligence Drug Development Segment by Type
2.2.1 Protein Structure Prediction
2.2.2 Structure-Based Drug Design
2.2.3 Ligand-Based Drug Design
2.2.4 Generative AI Molecular Design
2.2.5 Multi-Omics Integrated Analysis
2.2.6 ADMET Property Prediction
2.2.7 Knowledge Graph Drug Repurposing
2.2.8 Artificial Intelligence Drug Development Market Size by Type
2.2.8.1 Artificial Intelligence Drug Development Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.8.2 Global Artificial Intelligence Drug Development Market Size Market Share by Type (2021-2026)
2.3 Artificial Intelligence Drug Development Segment by Model Parameter Scale
2.3.1 Billion-Level Parameters
2.3.2 Ten-Billion-Level Parameters
2.3.3 Hundred-Billion-Level Parameters
2.3.4 Trillion-Level Parameters
2.3.5 Artificial Intelligence Drug Development Market Size by Model Parameter Scale
2.3.5.1 Artificial Intelligence Drug Development Market Size CAGR by Model Parameter Scale (2021 VS 2025 VS 2032)
2.3.5.2 Global Artificial Intelligence Drug Development Market Size Market Share by Model Parameter Scale (2021-2026)
2.4 Artificial Intelligence Drug Development Segment by Applicable Drug
2.4.1 Small Molecule Drugs
2.4.2 Antibody Drugs
2.4.3 Peptide Drugs
2.4.4 Nucleic Acid Drugs
2.4.5 Vaccines
2.4.6 Synthetic Biology Drugs
2.4.7 Artificial Intelligence Drug Development Market Size by Applicable Drug
2.4.7.1 Artificial Intelligence Drug Development Market Size CAGR by Applicable Drug (2021 VS 2025 VS 2032)
2.4.7.2 Global Artificial Intelligence Drug Development Market Size Market Share by Applicable Drug (2021-2026)
2.5 Artificial Intelligence Drug Development Segment by Application
2.5.1 Oncology Therapeutics
2.5.2 Infectious Disease Drugs
2.5.3 Neurological Disorder Drugs
2.5.4 Cardiovascular Disease Drugs
2.5.5 Rare Disease Drugs
2.5.6 Autoimmune Disease Drugs
2.5.7 Artificial Intelligence Drug Development Market Size by Application
2.5.7.1 Artificial Intelligence Drug Development Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.5.7.2 Global Artificial Intelligence Drug Development Market Size Market Share by Application (2021-2026)
3 ARTIFICIAL INTELLIGENCE DRUG DEVELOPMENT MARKET SIZE BY PLAYER
3.1 Artificial Intelligence Drug Development Market Size Market Share by Player
3.1.1 Global Artificial Intelligence Drug Development Revenue by Player (2021-2026)
3.1.2 Global Artificial Intelligence Drug Development Revenue Market Share by Player (2021-2026)
3.2 Global Artificial Intelligence Drug Development Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 ARTIFICIAL INTELLIGENCE DRUG DEVELOPMENT BY REGION
4.1 Artificial Intelligence Drug Development Market Size by Region (2021-2026)
4.2 Global Artificial Intelligence Drug Development Annual Revenue by Country/Region (2021-2026)
4.3 Americas Artificial Intelligence Drug Development Market Size Growth (2021-2026)
4.4 APAC Artificial Intelligence Drug Development Market Size Growth (2021-2026)
4.5 Europe Artificial Intelligence Drug Development Market Size Growth (2021-2026)
4.6 Middle East & Africa Artificial Intelligence Drug Development Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Artificial Intelligence Drug Development Market Size by Country (2021-2026)
5.2 Americas Artificial Intelligence Drug Development Market Size by Type (2021-2026)
5.3 Americas Artificial Intelligence Drug Development Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Artificial Intelligence Drug Development Market Size by Region (2021-2026)
6.2 APAC Artificial Intelligence Drug Development Market Size by Type (2021-2026)
6.3 APAC Artificial Intelligence Drug Development Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Artificial Intelligence Drug Development Market Size by Country (2021-2026)
7.2 Europe Artificial Intelligence Drug Development Market Size by Type (2021-2026)
7.3 Europe Artificial Intelligence Drug Development Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Artificial Intelligence Drug Development by Region (2021-2026)
8.2 Middle East & Africa Artificial Intelligence Drug Development Market Size by Type (2021-2026)
8.3 Middle East & Africa Artificial Intelligence Drug Development Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL ARTIFICIAL INTELLIGENCE DRUG DEVELOPMENT MARKET FORECAST
10.1 Global Artificial Intelligence Drug Development Forecast by Region (2027-2032)
10.1.1 Global Artificial Intelligence Drug Development Forecast by Region (2027-2032)
10.1.2 Americas Artificial Intelligence Drug Development Forecast
10.1.3 APAC Artificial Intelligence Drug Development Forecast
10.1.4 Europe Artificial Intelligence Drug Development Forecast
10.1.5 Middle East & Africa Artificial Intelligence Drug Development Forecast
10.2 Americas Artificial Intelligence Drug Development Forecast by Country (2027-2032)
10.2.1 United States Market Artificial Intelligence Drug Development Forecast
10.2.2 Canada Market Artificial Intelligence Drug Development Forecast
10.2.3 Mexico Market Artificial Intelligence Drug Development Forecast
10.2.4 Brazil Market Artificial Intelligence Drug Development Forecast
10.3 APAC Artificial Intelligence Drug Development Forecast by Region (2027-2032)
10.3.1 China Artificial Intelligence Drug Development Market Forecast
10.3.2 Japan Market Artificial Intelligence Drug Development Forecast
10.3.3 Korea Market Artificial Intelligence Drug Development Forecast
10.3.4 Southeast Asia Market Artificial Intelligence Drug Development Forecast
10.3.5 India Market Artificial Intelligence Drug Development Forecast
10.3.6 Australia Market Artificial Intelligence Drug Development Forecast
10.4 Europe Artificial Intelligence Drug Development Forecast by Country (2027-2032)
10.4.1 Germany Market Artificial Intelligence Drug Development Forecast
10.4.2 France Market Artificial Intelligence Drug Development Forecast
10.4.3 UK Market Artificial Intelligence Drug Development Forecast
10.4.4 Italy Market Artificial Intelligence Drug Development Forecast
10.4.5 Russia Market Artificial Intelligence Drug Development Forecast
10.5 Middle East & Africa Artificial Intelligence Drug Development Forecast by Region (2027-2032)
10.5.1 Egypt Market Artificial Intelligence Drug Development Forecast
10.5.2 South Africa Market Artificial Intelligence Drug Development Forecast
10.5.3 Israel Market Artificial Intelligence Drug Development Forecast
10.5.4 Turkey Market Artificial Intelligence Drug Development Forecast
10.6 Global Artificial Intelligence Drug Development Forecast by Type (2027-2032)
10.7 Global Artificial Intelligence Drug Development Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Artificial Intelligence Drug Development Forecast
11 KEY PLAYERS ANALYSIS
11.1 Insilico Medicine
11.1.1 Insilico Medicine Company Information
11.1.2 Insilico Medicine Artificial Intelligence Drug Development Product Offered
11.1.3 Insilico Medicine Artificial Intelligence Drug Development Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 Insilico Medicine Main Business Overview
11.1.5 Insilico Medicine Latest Developments
11.2 Schr?dinger
11.2.1 Schr?dinger Company Information
11.2.2 Schr?dinger Artificial Intelligence Drug Development Product Offered
11.2.3 Schr?dinger Artificial Intelligence Drug Development Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Schr?dinger Main Business Overview
11.2.5 Schr?dinger Latest Developments
11.3 Recursion
11.3.1 Recursion Company Information
11.3.2 Recursion Artificial Intelligence Drug Development Product Offered
11.3.3 Recursion Artificial Intelligence Drug Development Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Recursion Main Business Overview
11.3.5 Recursion Latest Developments
11.4 BenevolentAI
11.4.1 BenevolentAI Company Information
11.4.2 BenevolentAI Artificial Intelligence Drug Development Product Offered
11.4.3 BenevolentAI Artificial Intelligence Drug Development Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 BenevolentAI Main Business Overview
11.4.5 BenevolentAI Latest Developments
11.5 Owkin
11.5.1 Owkin Company Information
11.5.2 Owkin Artificial Intelligence Drug Development Product Offered
11.5.3 Owkin Artificial Intelligence Drug Development Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 Owkin Main Business Overview
11.5.5 Owkin Latest Developments
11.6 Valo Health
11.6.1 Valo Health Company Information
11.6.2 Valo Health Artificial Intelligence Drug Development Product Offered
11.6.3 Valo Health Artificial Intelligence Drug Development Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 Valo Health Main Business Overview
11.6.5 Valo Health Latest Developments
11.7 XtalPi
11.7.1 XtalPi Company Information
11.7.2 XtalPi Artificial Intelligence Drug Development Product Offered
11.7.3 XtalPi Artificial Intelligence Drug Development Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 XtalPi Main Business Overview
11.7.5 XtalPi Latest Developments
11.8 Standigm
11.8.1 Standigm Company Information
11.8.2 Standigm Artificial Intelligence Drug Development Product Offered
11.8.3 Standigm Artificial Intelligence Drug Development Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 Standigm Main Business Overview
11.8.5 Standigm Latest Developments
11.9 Evaxion Biotech
11.9.1 Evaxion Biotech Company Information
11.9.2 Evaxion Biotech Artificial Intelligence Drug Development Product Offered
11.9.3 Evaxion Biotech Artificial Intelligence Drug Development Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 Evaxion Biotech Main Business Overview
11.9.5 Evaxion Biotech Latest Developments
11.10 AbCellera
11.10.1 AbCellera Company Information
11.10.2 AbCellera Artificial Intelligence Drug Development Product Offered
11.10.3 AbCellera Artificial Intelligence Drug Development Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 AbCellera Main Business Overview
11.10.5 AbCellera Latest Developments
11.11 Absci
11.11.1 Absci Company Information
11.11.2 Absci Artificial Intelligence Drug Development Product Offered
11.11.3 Absci Artificial Intelligence Drug Development Revenue, Gross Margin and Market Share (2021-2026)
11.11.4 Absci Main Business Overview
11.11.5 Absci Latest Developments
11.12 Iktos
11.12.1 Iktos Company Information
11.12.2 Iktos Artificial Intelligence Drug Development Product Offered
11.12.3 Iktos Artificial Intelligence Drug Development Revenue, Gross Margin and Market Share (2021-2026)
11.12.4 Iktos Main Business Overview
11.12.5 Iktos Latest Developments
11.13 BioMap
11.13.1 BioMap Company Information
11.13.2 BioMap Artificial Intelligence Drug Development Product Offered
11.13.3 BioMap Artificial Intelligence Drug Development Revenue, Gross Margin and Market Share (2021-2026)
11.13.4 BioMap Main Business Overview
11.13.5 BioMap Latest Developments
11.14 Genialis
11.14.1 Genialis Company Information
11.14.2 Genialis Artificial Intelligence Drug Development Product Offered
11.14.3 Genialis Artificial Intelligence Drug Development Revenue, Gross Margin and Market Share (2021-2026)
11.14.4 Genialis Main Business Overview
11.14.5 Genialis Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Artificial Intelligence Drug Development Market Size (2021-2032)
2.1.2 Artificial Intelligence Drug Development Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Artificial Intelligence Drug Development by Country/Region (2021, 2025 & 2032)
2.2 Artificial Intelligence Drug Development Segment by Type
2.2.1 Protein Structure Prediction
2.2.2 Structure-Based Drug Design
2.2.3 Ligand-Based Drug Design
2.2.4 Generative AI Molecular Design
2.2.5 Multi-Omics Integrated Analysis
2.2.6 ADMET Property Prediction
2.2.7 Knowledge Graph Drug Repurposing
2.2.8 Artificial Intelligence Drug Development Market Size by Type
2.2.8.1 Artificial Intelligence Drug Development Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.8.2 Global Artificial Intelligence Drug Development Market Size Market Share by Type (2021-2026)
2.3 Artificial Intelligence Drug Development Segment by Model Parameter Scale
2.3.1 Billion-Level Parameters
2.3.2 Ten-Billion-Level Parameters
2.3.3 Hundred-Billion-Level Parameters
2.3.4 Trillion-Level Parameters
2.3.5 Artificial Intelligence Drug Development Market Size by Model Parameter Scale
2.3.5.1 Artificial Intelligence Drug Development Market Size CAGR by Model Parameter Scale (2021 VS 2025 VS 2032)
2.3.5.2 Global Artificial Intelligence Drug Development Market Size Market Share by Model Parameter Scale (2021-2026)
2.4 Artificial Intelligence Drug Development Segment by Applicable Drug
2.4.1 Small Molecule Drugs
2.4.2 Antibody Drugs
2.4.3 Peptide Drugs
2.4.4 Nucleic Acid Drugs
2.4.5 Vaccines
2.4.6 Synthetic Biology Drugs
2.4.7 Artificial Intelligence Drug Development Market Size by Applicable Drug
2.4.7.1 Artificial Intelligence Drug Development Market Size CAGR by Applicable Drug (2021 VS 2025 VS 2032)
2.4.7.2 Global Artificial Intelligence Drug Development Market Size Market Share by Applicable Drug (2021-2026)
2.5 Artificial Intelligence Drug Development Segment by Application
2.5.1 Oncology Therapeutics
2.5.2 Infectious Disease Drugs
2.5.3 Neurological Disorder Drugs
2.5.4 Cardiovascular Disease Drugs
2.5.5 Rare Disease Drugs
2.5.6 Autoimmune Disease Drugs
2.5.7 Artificial Intelligence Drug Development Market Size by Application
2.5.7.1 Artificial Intelligence Drug Development Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.5.7.2 Global Artificial Intelligence Drug Development Market Size Market Share by Application (2021-2026)
3 ARTIFICIAL INTELLIGENCE DRUG DEVELOPMENT MARKET SIZE BY PLAYER
3.1 Artificial Intelligence Drug Development Market Size Market Share by Player
3.1.1 Global Artificial Intelligence Drug Development Revenue by Player (2021-2026)
3.1.2 Global Artificial Intelligence Drug Development Revenue Market Share by Player (2021-2026)
3.2 Global Artificial Intelligence Drug Development Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 ARTIFICIAL INTELLIGENCE DRUG DEVELOPMENT BY REGION
4.1 Artificial Intelligence Drug Development Market Size by Region (2021-2026)
4.2 Global Artificial Intelligence Drug Development Annual Revenue by Country/Region (2021-2026)
4.3 Americas Artificial Intelligence Drug Development Market Size Growth (2021-2026)
4.4 APAC Artificial Intelligence Drug Development Market Size Growth (2021-2026)
4.5 Europe Artificial Intelligence Drug Development Market Size Growth (2021-2026)
4.6 Middle East & Africa Artificial Intelligence Drug Development Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Artificial Intelligence Drug Development Market Size by Country (2021-2026)
5.2 Americas Artificial Intelligence Drug Development Market Size by Type (2021-2026)
5.3 Americas Artificial Intelligence Drug Development Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Artificial Intelligence Drug Development Market Size by Region (2021-2026)
6.2 APAC Artificial Intelligence Drug Development Market Size by Type (2021-2026)
6.3 APAC Artificial Intelligence Drug Development Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Artificial Intelligence Drug Development Market Size by Country (2021-2026)
7.2 Europe Artificial Intelligence Drug Development Market Size by Type (2021-2026)
7.3 Europe Artificial Intelligence Drug Development Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Artificial Intelligence Drug Development by Region (2021-2026)
8.2 Middle East & Africa Artificial Intelligence Drug Development Market Size by Type (2021-2026)
8.3 Middle East & Africa Artificial Intelligence Drug Development Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL ARTIFICIAL INTELLIGENCE DRUG DEVELOPMENT MARKET FORECAST
10.1 Global Artificial Intelligence Drug Development Forecast by Region (2027-2032)
10.1.1 Global Artificial Intelligence Drug Development Forecast by Region (2027-2032)
10.1.2 Americas Artificial Intelligence Drug Development Forecast
10.1.3 APAC Artificial Intelligence Drug Development Forecast
10.1.4 Europe Artificial Intelligence Drug Development Forecast
10.1.5 Middle East & Africa Artificial Intelligence Drug Development Forecast
10.2 Americas Artificial Intelligence Drug Development Forecast by Country (2027-2032)
10.2.1 United States Market Artificial Intelligence Drug Development Forecast
10.2.2 Canada Market Artificial Intelligence Drug Development Forecast
10.2.3 Mexico Market Artificial Intelligence Drug Development Forecast
10.2.4 Brazil Market Artificial Intelligence Drug Development Forecast
10.3 APAC Artificial Intelligence Drug Development Forecast by Region (2027-2032)
10.3.1 China Artificial Intelligence Drug Development Market Forecast
10.3.2 Japan Market Artificial Intelligence Drug Development Forecast
10.3.3 Korea Market Artificial Intelligence Drug Development Forecast
10.3.4 Southeast Asia Market Artificial Intelligence Drug Development Forecast
10.3.5 India Market Artificial Intelligence Drug Development Forecast
10.3.6 Australia Market Artificial Intelligence Drug Development Forecast
10.4 Europe Artificial Intelligence Drug Development Forecast by Country (2027-2032)
10.4.1 Germany Market Artificial Intelligence Drug Development Forecast
10.4.2 France Market Artificial Intelligence Drug Development Forecast
10.4.3 UK Market Artificial Intelligence Drug Development Forecast
10.4.4 Italy Market Artificial Intelligence Drug Development Forecast
10.4.5 Russia Market Artificial Intelligence Drug Development Forecast
10.5 Middle East & Africa Artificial Intelligence Drug Development Forecast by Region (2027-2032)
10.5.1 Egypt Market Artificial Intelligence Drug Development Forecast
10.5.2 South Africa Market Artificial Intelligence Drug Development Forecast
10.5.3 Israel Market Artificial Intelligence Drug Development Forecast
10.5.4 Turkey Market Artificial Intelligence Drug Development Forecast
10.6 Global Artificial Intelligence Drug Development Forecast by Type (2027-2032)
10.7 Global Artificial Intelligence Drug Development Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Artificial Intelligence Drug Development Forecast
11 KEY PLAYERS ANALYSIS
11.1 Insilico Medicine
11.1.1 Insilico Medicine Company Information
11.1.2 Insilico Medicine Artificial Intelligence Drug Development Product Offered
11.1.3 Insilico Medicine Artificial Intelligence Drug Development Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 Insilico Medicine Main Business Overview
11.1.5 Insilico Medicine Latest Developments
11.2 Schr?dinger
11.2.1 Schr?dinger Company Information
11.2.2 Schr?dinger Artificial Intelligence Drug Development Product Offered
11.2.3 Schr?dinger Artificial Intelligence Drug Development Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Schr?dinger Main Business Overview
11.2.5 Schr?dinger Latest Developments
11.3 Recursion
11.3.1 Recursion Company Information
11.3.2 Recursion Artificial Intelligence Drug Development Product Offered
11.3.3 Recursion Artificial Intelligence Drug Development Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Recursion Main Business Overview
11.3.5 Recursion Latest Developments
11.4 BenevolentAI
11.4.1 BenevolentAI Company Information
11.4.2 BenevolentAI Artificial Intelligence Drug Development Product Offered
11.4.3 BenevolentAI Artificial Intelligence Drug Development Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 BenevolentAI Main Business Overview
11.4.5 BenevolentAI Latest Developments
11.5 Owkin
11.5.1 Owkin Company Information
11.5.2 Owkin Artificial Intelligence Drug Development Product Offered
11.5.3 Owkin Artificial Intelligence Drug Development Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 Owkin Main Business Overview
11.5.5 Owkin Latest Developments
11.6 Valo Health
11.6.1 Valo Health Company Information
11.6.2 Valo Health Artificial Intelligence Drug Development Product Offered
11.6.3 Valo Health Artificial Intelligence Drug Development Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 Valo Health Main Business Overview
11.6.5 Valo Health Latest Developments
11.7 XtalPi
11.7.1 XtalPi Company Information
11.7.2 XtalPi Artificial Intelligence Drug Development Product Offered
11.7.3 XtalPi Artificial Intelligence Drug Development Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 XtalPi Main Business Overview
11.7.5 XtalPi Latest Developments
11.8 Standigm
11.8.1 Standigm Company Information
11.8.2 Standigm Artificial Intelligence Drug Development Product Offered
11.8.3 Standigm Artificial Intelligence Drug Development Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 Standigm Main Business Overview
11.8.5 Standigm Latest Developments
11.9 Evaxion Biotech
11.9.1 Evaxion Biotech Company Information
11.9.2 Evaxion Biotech Artificial Intelligence Drug Development Product Offered
11.9.3 Evaxion Biotech Artificial Intelligence Drug Development Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 Evaxion Biotech Main Business Overview
11.9.5 Evaxion Biotech Latest Developments
11.10 AbCellera
11.10.1 AbCellera Company Information
11.10.2 AbCellera Artificial Intelligence Drug Development Product Offered
11.10.3 AbCellera Artificial Intelligence Drug Development Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 AbCellera Main Business Overview
11.10.5 AbCellera Latest Developments
11.11 Absci
11.11.1 Absci Company Information
11.11.2 Absci Artificial Intelligence Drug Development Product Offered
11.11.3 Absci Artificial Intelligence Drug Development Revenue, Gross Margin and Market Share (2021-2026)
11.11.4 Absci Main Business Overview
11.11.5 Absci Latest Developments
11.12 Iktos
11.12.1 Iktos Company Information
11.12.2 Iktos Artificial Intelligence Drug Development Product Offered
11.12.3 Iktos Artificial Intelligence Drug Development Revenue, Gross Margin and Market Share (2021-2026)
11.12.4 Iktos Main Business Overview
11.12.5 Iktos Latest Developments
11.13 BioMap
11.13.1 BioMap Company Information
11.13.2 BioMap Artificial Intelligence Drug Development Product Offered
11.13.3 BioMap Artificial Intelligence Drug Development Revenue, Gross Margin and Market Share (2021-2026)
11.13.4 BioMap Main Business Overview
11.13.5 BioMap Latest Developments
11.14 Genialis
11.14.1 Genialis Company Information
11.14.2 Genialis Artificial Intelligence Drug Development Product Offered
11.14.3 Genialis Artificial Intelligence Drug Development Revenue, Gross Margin and Market Share (2021-2026)
11.14.4 Genialis Main Business Overview
11.14.5 Genialis Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Artificial Intelligence Drug Development Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Artificial Intelligence Drug Development Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Protein Structure Prediction
Table 4. Major Players of Structure-Based Drug Design
Table 5. Major Players of Ligand-Based Drug Design
Table 6. Major Players of Generative AI Molecular Design
Table 7. Major Players of Multi-Omics Integrated Analysis
Table 8. Major Players of ADMET Property Prediction
Table 9. Major Players of Knowledge Graph Drug Repurposing
Table 10. Artificial Intelligence Drug Development Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 11. Global Artificial Intelligence Drug Development Market Size by Type (2021-2026) & ($ millions)
Table 12. Global Artificial Intelligence Drug Development Market Size Market Share by Type (2021-2026)
Table 13. Major Players of Billion-Level Parameters
Table 14. Major Players of Ten-Billion-Level Parameters
Table 15. Major Players of Hundred-Billion-Level Parameters
Table 16. Major Players of Trillion-Level Parameters
Table 17. Artificial Intelligence Drug Development Market Size CAGR by Model Parameter Scale (2021 VS 2025 VS 2032) & ($ millions)
Table 18. Global Artificial Intelligence Drug Development Market Size by Model Parameter Scale (2021-2026) & ($ millions)
Table 19. Global Artificial Intelligence Drug Development Market Size Market Share by Model Parameter Scale (2021-2026)
Table 20. Major Players of Small Molecule Drugs
Table 21. Major Players of Antibody Drugs
Table 22. Major Players of Peptide Drugs
Table 23. Major Players of Nucleic Acid Drugs
Table 24. Major Players of Vaccines
Table 25. Major Players of Synthetic Biology Drugs
Table 26. Artificial Intelligence Drug Development Market Size CAGR by Applicable Drug (2021 VS 2025 VS 2032) & ($ millions)
Table 27. Global Artificial Intelligence Drug Development Market Size by Applicable Drug (2021-2026) & ($ millions)
Table 28. Global Artificial Intelligence Drug Development Market Size Market Share by Applicable Drug (2021-2026)
Table 29. Artificial Intelligence Drug Development Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 30. Global Artificial Intelligence Drug Development Market Size by Application (2021-2026) & ($ millions)
Table 31. Global Artificial Intelligence Drug Development Market Size Market Share by Application (2021-2026)
Table 32. Global Artificial Intelligence Drug Development Revenue by Player (2021-2026) & ($ millions)
Table 33. Global Artificial Intelligence Drug Development Revenue Market Share by Player (2021-2026)
Table 34. Artificial Intelligence Drug Development Key Players Head office and Products Offered
Table 35. Artificial Intelligence Drug Development Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 36. New Products and Potential Entrants
Table 37. Mergers & Acquisitions, Expansion
Table 38. Global Artificial Intelligence Drug Development Market Size by Region (2021-2026) & ($ millions)
Table 39. Global Artificial Intelligence Drug Development Market Size Market Share by Region (2021-2026)
Table 40. Global Artificial Intelligence Drug Development Revenue by Country/Region (2021-2026) & ($ millions)
Table 41. Global Artificial Intelligence Drug Development Revenue Market Share by Country/Region (2021-2026)
Table 42. Americas Artificial Intelligence Drug Development Market Size by Country (2021-2026) & ($ millions)
Table 43. Americas Artificial Intelligence Drug Development Market Size Market Share by Country (2021-2026)
Table 44. Americas Artificial Intelligence Drug Development Market Size by Type (2021-2026) & ($ millions)
Table 45. Americas Artificial Intelligence Drug Development Market Size Market Share by Type (2021-2026)
Table 46. Americas Artificial Intelligence Drug Development Market Size by Application (2021-2026) & ($ millions)
Table 47. Americas Artificial Intelligence Drug Development Market Size Market Share by Application (2021-2026)
Table 48. APAC Artificial Intelligence Drug Development Market Size by Region (2021-2026) & ($ millions)
Table 49. APAC Artificial Intelligence Drug Development Market Size Market Share by Region (2021-2026)
Table 50. APAC Artificial Intelligence Drug Development Market Size by Type (2021-2026) & ($ millions)
Table 51. APAC Artificial Intelligence Drug Development Market Size by Application (2021-2026) & ($ millions)
Table 52. Europe Artificial Intelligence Drug Development Market Size by Country (2021-2026) & ($ millions)
Table 53. Europe Artificial Intelligence Drug Development Market Size Market Share by Country (2021-2026)
Table 54. Europe Artificial Intelligence Drug Development Market Size by Type (2021-2026) & ($ millions)
Table 55. Europe Artificial Intelligence Drug Development Market Size by Application (2021-2026) & ($ millions)
Table 56. Middle East & Africa Artificial Intelligence Drug Development Market Size by Region (2021-2026) & ($ millions)
Table 57. Middle East & Africa Artificial Intelligence Drug Development Market Size by Type (2021-2026) & ($ millions)
Table 58. Middle East & Africa Artificial Intelligence Drug Development Market Size by Application (2021-2026) & ($ millions)
Table 59. Key Market Drivers & Growth Opportunities of Artificial Intelligence Drug Development
Table 60. Key Market Challenges & Risks of Artificial Intelligence Drug Development
Table 61. Key Industry Trends of Artificial Intelligence Drug Development
Table 62. Global Artificial Intelligence Drug Development Market Size Forecast by Region (2027-2032) & ($ millions)
Table 63. Global Artificial Intelligence Drug Development Market Size Market Share Forecast by Region (2027-2032)
Table 64. Global Artificial Intelligence Drug Development Market Size Forecast by Type (2027-2032) & ($ millions)
Table 65. Global Artificial Intelligence Drug Development Market Size Forecast by Application (2027-2032) & ($ millions)
Table 66. Insilico Medicine Details, Company Type, Artificial Intelligence Drug Development Area Served and Its Competitors
Table 67. Insilico Medicine Artificial Intelligence Drug Development Product Offered
Table 68. Insilico Medicine Artificial Intelligence Drug Development Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 69. Insilico Medicine Main Business
Table 70. Insilico Medicine Latest Developments
Table 71. Schr?dinger Details, Company Type, Artificial Intelligence Drug Development Area Served and Its Competitors
Table 72. Schr?dinger Artificial Intelligence Drug Development Product Offered
Table 73. Schr?dinger Artificial Intelligence Drug Development Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 74. Schr?dinger Main Business
Table 75. Schr?dinger Latest Developments
Table 76. Recursion Details, Company Type, Artificial Intelligence Drug Development Area Served and Its Competitors
Table 77. Recursion Artificial Intelligence Drug Development Product Offered
Table 78. Recursion Artificial Intelligence Drug Development Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 79. Recursion Main Business
Table 80. Recursion Latest Developments
Table 81. BenevolentAI Details, Company Type, Artificial Intelligence Drug Development Area Served and Its Competitors
Table 82. BenevolentAI Artificial Intelligence Drug Development Product Offered
Table 83. BenevolentAI Artificial Intelligence Drug Development Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 84. BenevolentAI Main Business
Table 85. BenevolentAI Latest Developments
Table 86. Owkin Details, Company Type, Artificial Intelligence Drug Development Area Served and Its Competitors
Table 87. Owkin Artificial Intelligence Drug Development Product Offered
Table 88. Owkin Artificial Intelligence Drug Development Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 89. Owkin Main Business
Table 90. Owkin Latest Developments
Table 91. Valo Health Details, Company Type, Artificial Intelligence Drug Development Area Served and Its Competitors
Table 92. Valo Health Artificial Intelligence Drug Development Product Offered
Table 93. Valo Health Artificial Intelligence Drug Development Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 94. Valo Health Main Business
Table 95. Valo Health Latest Developments
Table 96. XtalPi Details, Company Type, Artificial Intelligence Drug Development Area Served and Its Competitors
Table 97. XtalPi Artificial Intelligence Drug Development Product Offered
Table 98. XtalPi Artificial Intelligence Drug Development Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 99. XtalPi Main Business
Table 100. XtalPi Latest Developments
Table 101. Standigm Details, Company Type, Artificial Intelligence Drug Development Area Served and Its Competitors
Table 102. Standigm Artificial Intelligence Drug Development Product Offered
Table 103. Standigm Artificial Intelligence Drug Development Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 104. Standigm Main Business
Table 105. Standigm Latest Developments
Table 106. Evaxion Biotech Details, Company Type, Artificial Intelligence Drug Development Area Served and Its Competitors
Table 107. Evaxion Biotech Artificial Intelligence Drug Development Product Offered
Table 108. Evaxion Biotech Artificial Intelligence Drug Development Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 109. Evaxion Biotech Main Business
Table 110. Evaxion Biotech Latest Developments
Table 111. AbCellera Details, Company Type, Artificial Intelligence Drug Development Area Served and Its Competitors
Table 112. AbCellera Artificial Intelligence Drug Development Product Offered
Table 113. AbCellera Artificial Intelligence Drug Development Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 114. AbCellera Main Business
Table 115. AbCellera Latest Developments
Table 116. Absci Details, Company Type, Artificial Intelligence Drug Development Area Served and Its Competitors
Table 117. Absci Artificial Intelligence Drug Development Product Offered
Table 118. Absci Artificial Intelligence Drug Development Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 119. Absci Main Business
Table 120. Absci Latest Developments
Table 121. Iktos Details, Company Type, Artificial Intelligence Drug Development Area Served and Its Competitors
Table 122. Iktos Artificial Intelligence Drug Development Product Offered
Table 123. Iktos Artificial Intelligence Drug Development Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 124. Iktos Main Business
Table 125. Iktos Latest Developments
Table 126. BioMap Details, Company Type, Artificial Intelligence Drug Development Area Served and Its Competitors
Table 127. BioMap Artificial Intelligence Drug Development Product Offered
Table 128. BioMap Artificial Intelligence Drug Development Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 129. BioMap Main Business
Table 130. BioMap Latest Developments
Table 131. Genialis Details, Company Type, Artificial Intelligence Drug Development Area Served and Its Competitors
Table 132. Genialis Artificial Intelligence Drug Development Product Offered
Table 133. Genialis Artificial Intelligence Drug Development Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 134. Genialis Main Business
Table 135. Genialis Latest Developments
Table 1. Artificial Intelligence Drug Development Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Artificial Intelligence Drug Development Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Protein Structure Prediction
Table 4. Major Players of Structure-Based Drug Design
Table 5. Major Players of Ligand-Based Drug Design
Table 6. Major Players of Generative AI Molecular Design
Table 7. Major Players of Multi-Omics Integrated Analysis
Table 8. Major Players of ADMET Property Prediction
Table 9. Major Players of Knowledge Graph Drug Repurposing
Table 10. Artificial Intelligence Drug Development Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 11. Global Artificial Intelligence Drug Development Market Size by Type (2021-2026) & ($ millions)
Table 12. Global Artificial Intelligence Drug Development Market Size Market Share by Type (2021-2026)
Table 13. Major Players of Billion-Level Parameters
Table 14. Major Players of Ten-Billion-Level Parameters
Table 15. Major Players of Hundred-Billion-Level Parameters
Table 16. Major Players of Trillion-Level Parameters
Table 17. Artificial Intelligence Drug Development Market Size CAGR by Model Parameter Scale (2021 VS 2025 VS 2032) & ($ millions)
Table 18. Global Artificial Intelligence Drug Development Market Size by Model Parameter Scale (2021-2026) & ($ millions)
Table 19. Global Artificial Intelligence Drug Development Market Size Market Share by Model Parameter Scale (2021-2026)
Table 20. Major Players of Small Molecule Drugs
Table 21. Major Players of Antibody Drugs
Table 22. Major Players of Peptide Drugs
Table 23. Major Players of Nucleic Acid Drugs
Table 24. Major Players of Vaccines
Table 25. Major Players of Synthetic Biology Drugs
Table 26. Artificial Intelligence Drug Development Market Size CAGR by Applicable Drug (2021 VS 2025 VS 2032) & ($ millions)
Table 27. Global Artificial Intelligence Drug Development Market Size by Applicable Drug (2021-2026) & ($ millions)
Table 28. Global Artificial Intelligence Drug Development Market Size Market Share by Applicable Drug (2021-2026)
Table 29. Artificial Intelligence Drug Development Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 30. Global Artificial Intelligence Drug Development Market Size by Application (2021-2026) & ($ millions)
Table 31. Global Artificial Intelligence Drug Development Market Size Market Share by Application (2021-2026)
Table 32. Global Artificial Intelligence Drug Development Revenue by Player (2021-2026) & ($ millions)
Table 33. Global Artificial Intelligence Drug Development Revenue Market Share by Player (2021-2026)
Table 34. Artificial Intelligence Drug Development Key Players Head office and Products Offered
Table 35. Artificial Intelligence Drug Development Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 36. New Products and Potential Entrants
Table 37. Mergers & Acquisitions, Expansion
Table 38. Global Artificial Intelligence Drug Development Market Size by Region (2021-2026) & ($ millions)
Table 39. Global Artificial Intelligence Drug Development Market Size Market Share by Region (2021-2026)
Table 40. Global Artificial Intelligence Drug Development Revenue by Country/Region (2021-2026) & ($ millions)
Table 41. Global Artificial Intelligence Drug Development Revenue Market Share by Country/Region (2021-2026)
Table 42. Americas Artificial Intelligence Drug Development Market Size by Country (2021-2026) & ($ millions)
Table 43. Americas Artificial Intelligence Drug Development Market Size Market Share by Country (2021-2026)
Table 44. Americas Artificial Intelligence Drug Development Market Size by Type (2021-2026) & ($ millions)
Table 45. Americas Artificial Intelligence Drug Development Market Size Market Share by Type (2021-2026)
Table 46. Americas Artificial Intelligence Drug Development Market Size by Application (2021-2026) & ($ millions)
Table 47. Americas Artificial Intelligence Drug Development Market Size Market Share by Application (2021-2026)
Table 48. APAC Artificial Intelligence Drug Development Market Size by Region (2021-2026) & ($ millions)
Table 49. APAC Artificial Intelligence Drug Development Market Size Market Share by Region (2021-2026)
Table 50. APAC Artificial Intelligence Drug Development Market Size by Type (2021-2026) & ($ millions)
Table 51. APAC Artificial Intelligence Drug Development Market Size by Application (2021-2026) & ($ millions)
Table 52. Europe Artificial Intelligence Drug Development Market Size by Country (2021-2026) & ($ millions)
Table 53. Europe Artificial Intelligence Drug Development Market Size Market Share by Country (2021-2026)
Table 54. Europe Artificial Intelligence Drug Development Market Size by Type (2021-2026) & ($ millions)
Table 55. Europe Artificial Intelligence Drug Development Market Size by Application (2021-2026) & ($ millions)
Table 56. Middle East & Africa Artificial Intelligence Drug Development Market Size by Region (2021-2026) & ($ millions)
Table 57. Middle East & Africa Artificial Intelligence Drug Development Market Size by Type (2021-2026) & ($ millions)
Table 58. Middle East & Africa Artificial Intelligence Drug Development Market Size by Application (2021-2026) & ($ millions)
Table 59. Key Market Drivers & Growth Opportunities of Artificial Intelligence Drug Development
Table 60. Key Market Challenges & Risks of Artificial Intelligence Drug Development
Table 61. Key Industry Trends of Artificial Intelligence Drug Development
Table 62. Global Artificial Intelligence Drug Development Market Size Forecast by Region (2027-2032) & ($ millions)
Table 63. Global Artificial Intelligence Drug Development Market Size Market Share Forecast by Region (2027-2032)
Table 64. Global Artificial Intelligence Drug Development Market Size Forecast by Type (2027-2032) & ($ millions)
Table 65. Global Artificial Intelligence Drug Development Market Size Forecast by Application (2027-2032) & ($ millions)
Table 66. Insilico Medicine Details, Company Type, Artificial Intelligence Drug Development Area Served and Its Competitors
Table 67. Insilico Medicine Artificial Intelligence Drug Development Product Offered
Table 68. Insilico Medicine Artificial Intelligence Drug Development Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 69. Insilico Medicine Main Business
Table 70. Insilico Medicine Latest Developments
Table 71. Schr?dinger Details, Company Type, Artificial Intelligence Drug Development Area Served and Its Competitors
Table 72. Schr?dinger Artificial Intelligence Drug Development Product Offered
Table 73. Schr?dinger Artificial Intelligence Drug Development Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 74. Schr?dinger Main Business
Table 75. Schr?dinger Latest Developments
Table 76. Recursion Details, Company Type, Artificial Intelligence Drug Development Area Served and Its Competitors
Table 77. Recursion Artificial Intelligence Drug Development Product Offered
Table 78. Recursion Artificial Intelligence Drug Development Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 79. Recursion Main Business
Table 80. Recursion Latest Developments
Table 81. BenevolentAI Details, Company Type, Artificial Intelligence Drug Development Area Served and Its Competitors
Table 82. BenevolentAI Artificial Intelligence Drug Development Product Offered
Table 83. BenevolentAI Artificial Intelligence Drug Development Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 84. BenevolentAI Main Business
Table 85. BenevolentAI Latest Developments
Table 86. Owkin Details, Company Type, Artificial Intelligence Drug Development Area Served and Its Competitors
Table 87. Owkin Artificial Intelligence Drug Development Product Offered
Table 88. Owkin Artificial Intelligence Drug Development Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 89. Owkin Main Business
Table 90. Owkin Latest Developments
Table 91. Valo Health Details, Company Type, Artificial Intelligence Drug Development Area Served and Its Competitors
Table 92. Valo Health Artificial Intelligence Drug Development Product Offered
Table 93. Valo Health Artificial Intelligence Drug Development Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 94. Valo Health Main Business
Table 95. Valo Health Latest Developments
Table 96. XtalPi Details, Company Type, Artificial Intelligence Drug Development Area Served and Its Competitors
Table 97. XtalPi Artificial Intelligence Drug Development Product Offered
Table 98. XtalPi Artificial Intelligence Drug Development Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 99. XtalPi Main Business
Table 100. XtalPi Latest Developments
Table 101. Standigm Details, Company Type, Artificial Intelligence Drug Development Area Served and Its Competitors
Table 102. Standigm Artificial Intelligence Drug Development Product Offered
Table 103. Standigm Artificial Intelligence Drug Development Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 104. Standigm Main Business
Table 105. Standigm Latest Developments
Table 106. Evaxion Biotech Details, Company Type, Artificial Intelligence Drug Development Area Served and Its Competitors
Table 107. Evaxion Biotech Artificial Intelligence Drug Development Product Offered
Table 108. Evaxion Biotech Artificial Intelligence Drug Development Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 109. Evaxion Biotech Main Business
Table 110. Evaxion Biotech Latest Developments
Table 111. AbCellera Details, Company Type, Artificial Intelligence Drug Development Area Served and Its Competitors
Table 112. AbCellera Artificial Intelligence Drug Development Product Offered
Table 113. AbCellera Artificial Intelligence Drug Development Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 114. AbCellera Main Business
Table 115. AbCellera Latest Developments
Table 116. Absci Details, Company Type, Artificial Intelligence Drug Development Area Served and Its Competitors
Table 117. Absci Artificial Intelligence Drug Development Product Offered
Table 118. Absci Artificial Intelligence Drug Development Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 119. Absci Main Business
Table 120. Absci Latest Developments
Table 121. Iktos Details, Company Type, Artificial Intelligence Drug Development Area Served and Its Competitors
Table 122. Iktos Artificial Intelligence Drug Development Product Offered
Table 123. Iktos Artificial Intelligence Drug Development Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 124. Iktos Main Business
Table 125. Iktos Latest Developments
Table 126. BioMap Details, Company Type, Artificial Intelligence Drug Development Area Served and Its Competitors
Table 127. BioMap Artificial Intelligence Drug Development Product Offered
Table 128. BioMap Artificial Intelligence Drug Development Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 129. BioMap Main Business
Table 130. BioMap Latest Developments
Table 131. Genialis Details, Company Type, Artificial Intelligence Drug Development Area Served and Its Competitors
Table 132. Genialis Artificial Intelligence Drug Development Product Offered
Table 133. Genialis Artificial Intelligence Drug Development Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 134. Genialis Main Business
Table 135. Genialis Latest Developments
LIST OF FIGURES
Figure 1. Artificial Intelligence Drug Development Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Artificial Intelligence Drug Development Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Artificial Intelligence Drug Development Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Artificial Intelligence Drug Development Sales Market Share by Country/Region (2025)
Figure 8. Artificial Intelligence Drug Development Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Artificial Intelligence Drug Development Market Size Market Share by Type in 2025
Figure 10. Global Artificial Intelligence Drug Development Market Size Market Share by Model Parameter Scale in 2025
Figure 11. Global Artificial Intelligence Drug Development Market Size Market Share by Applicable Drug in 2025
Figure 12. Artificial Intelligence Drug Development in Oncology Therapeutics
Figure 13. Global Artificial Intelligence Drug Development Market: Oncology Therapeutics (2021-2026) & ($ millions)
Figure 14. Artificial Intelligence Drug Development in Infectious Disease Drugs
Figure 15. Global Artificial Intelligence Drug Development Market: Infectious Disease Drugs (2021-2026) & ($ millions)
Figure 16. Artificial Intelligence Drug Development in Neurological Disorder Drugs
Figure 17. Global Artificial Intelligence Drug Development Market: Neurological Disorder Drugs (2021-2026) & ($ millions)
Figure 18. Artificial Intelligence Drug Development in Cardiovascular Disease Drugs
Figure 19. Global Artificial Intelligence Drug Development Market: Cardiovascular Disease Drugs (2021-2026) & ($ millions)
Figure 20. Artificial Intelligence Drug Development in Rare Disease Drugs
Figure 21. Global Artificial Intelligence Drug Development Market: Rare Disease Drugs (2021-2026) & ($ millions)
Figure 22. Artificial Intelligence Drug Development in Autoimmune Disease Drugs
Figure 23. Global Artificial Intelligence Drug Development Market: Autoimmune Disease Drugs (2021-2026) & ($ millions)
Figure 24. Global Artificial Intelligence Drug Development Market Size Market Share by Application in 2025
Figure 25. Global Artificial Intelligence Drug Development Revenue Market Share by Player in 2025
Figure 26. Global Artificial Intelligence Drug Development Market Size Market Share by Region (2021-2026)
Figure 27. Americas Artificial Intelligence Drug Development Market Size 2021-2026 ($ millions)
Figure 28. APAC Artificial Intelligence Drug Development Market Size 2021-2026 ($ millions)
Figure 29. Europe Artificial Intelligence Drug Development Market Size 2021-2026 ($ millions)
Figure 30. Middle East & Africa Artificial Intelligence Drug Development Market Size 2021-2026 ($ millions)
Figure 31. Americas Artificial Intelligence Drug Development Value Market Share by Country in 2025
Figure 32. United States Artificial Intelligence Drug Development Market Size Growth 2021-2026 ($ millions)
Figure 33. Canada Artificial Intelligence Drug Development Market Size Growth 2021-2026 ($ millions)
Figure 34. Mexico Artificial Intelligence Drug Development Market Size Growth 2021-2026 ($ millions)
Figure 35. Brazil Artificial Intelligence Drug Development Market Size Growth 2021-2026 ($ millions)
Figure 36. APAC Artificial Intelligence Drug Development Market Size Market Share by Region in 2025
Figure 37. APAC Artificial Intelligence Drug Development Market Size Market Share by Type (2021-2026)
Figure 38. APAC Artificial Intelligence Drug Development Market Size Market Share by Application (2021-2026)
Figure 39. China Artificial Intelligence Drug Development Market Size Growth 2021-2026 ($ millions)
Figure 40. Japan Artificial Intelligence Drug Development Market Size Growth 2021-2026 ($ millions)
Figure 41. South Korea Artificial Intelligence Drug Development Market Size Growth 2021-2026 ($ millions)
Figure 42. Southeast Asia Artificial Intelligence Drug Development Market Size Growth 2021-2026 ($ millions)
Figure 43. India Artificial Intelligence Drug Development Market Size Growth 2021-2026 ($ millions)
Figure 44. Australia Artificial Intelligence Drug Development Market Size Growth 2021-2026 ($ millions)
Figure 45. Europe Artificial Intelligence Drug Development Market Size Market Share by Country in 2025
Figure 46. Europe Artificial Intelligence Drug Development Market Size Market Share by Type (2021-2026)
Figure 47. Europe Artificial Intelligence Drug Development Market Size Market Share by Application (2021-2026)
Figure 48. Germany Artificial Intelligence Drug Development Market Size Growth 2021-2026 ($ millions)
Figure 49. France Artificial Intelligence Drug Development Market Size Growth 2021-2026 ($ millions)
Figure 50. UK Artificial Intelligence Drug Development Market Size Growth 2021-2026 ($ millions)
Figure 51. Italy Artificial Intelligence Drug Development Market Size Growth 2021-2026 ($ millions)
Figure 52. Russia Artificial Intelligence Drug Development Market Size Growth 2021-2026 ($ millions)
Figure 53. Middle East & Africa Artificial Intelligence Drug Development Market Size Market Share by Region (2021-2026)
Figure 54. Middle East & Africa Artificial Intelligence Drug Development Market Size Market Share by Type (2021-2026)
Figure 55. Middle East & Africa Artificial Intelligence Drug Development Market Size Market Share by Application (2021-2026)
Figure 56. Egypt Artificial Intelligence Drug Development Market Size Growth 2021-2026 ($ millions)
Figure 57. South Africa Artificial Intelligence Drug Development Market Size Growth 2021-2026 ($ millions)
Figure 58. Israel Artificial Intelligence Drug Development Market Size Growth 2021-2026 ($ millions)
Figure 59. Turkey Artificial Intelligence Drug Development Market Size Growth 2021-2026 ($ millions)
Figure 60. GCC Countries Artificial Intelligence Drug Development Market Size Growth 2021-2026 ($ millions)
Figure 61. Americas Artificial Intelligence Drug Development Market Size 2027-2032 ($ millions)
Figure 62. APAC Artificial Intelligence Drug Development Market Size 2027-2032 ($ millions)
Figure 63. Europe Artificial Intelligence Drug Development Market Size 2027-2032 ($ millions)
Figure 64. Middle East & Africa Artificial Intelligence Drug Development Market Size 2027-2032 ($ millions)
Figure 65. United States Artificial Intelligence Drug Development Market Size 2027-2032 ($ millions)
Figure 66. Canada Artificial Intelligence Drug Development Market Size 2027-2032 ($ millions)
Figure 67. Mexico Artificial Intelligence Drug Development Market Size 2027-2032 ($ millions)
Figure 68. Brazil Artificial Intelligence Drug Development Market Size 2027-2032 ($ millions)
Figure 69. China Artificial Intelligence Drug Development Market Size 2027-2032 ($ millions)
Figure 70. Japan Artificial Intelligence Drug Development Market Size 2027-2032 ($ millions)
Figure 71. Korea Artificial Intelligence Drug Development Market Size 2027-2032 ($ millions)
Figure 72. Southeast Asia Artificial Intelligence Drug Development Market Size 2027-2032 ($ millions)
Figure 73. India Artificial Intelligence Drug Development Market Size 2027-2032 ($ millions)
Figure 74. Australia Artificial Intelligence Drug Development Market Size 2027-2032 ($ millions)
Figure 75. Germany Artificial Intelligence Drug Development Market Size 2027-2032 ($ millions)
Figure 76. France Artificial Intelligence Drug Development Market Size 2027-2032 ($ millions)
Figure 77. UK Artificial Intelligence Drug Development Market Size 2027-2032 ($ millions)
Figure 78. Italy Artificial Intelligence Drug Development Market Size 2027-2032 ($ millions)
Figure 79. Russia Artificial Intelligence Drug Development Market Size 2027-2032 ($ millions)
Figure 80. Egypt Artificial Intelligence Drug Development Market Size 2027-2032 ($ millions)
Figure 81. South Africa Artificial Intelligence Drug Development Market Size 2027-2032 ($ millions)
Figure 82. Israel Artificial Intelligence Drug Development Market Size 2027-2032 ($ millions)
Figure 83. Turkey Artificial Intelligence Drug Development Market Size 2027-2032 ($ millions)
Figure 84. Global Artificial Intelligence Drug Development Market Size Market Share Forecast by Type (2027-2032)
Figure 85. Global Artificial Intelligence Drug Development Market Size Market Share Forecast by Application (2027-2032)
Figure 86. GCC Countries Artificial Intelligence Drug Development Market Size 2027-2032 ($ millions)
Figure 1. Artificial Intelligence Drug Development Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Artificial Intelligence Drug Development Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Artificial Intelligence Drug Development Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Artificial Intelligence Drug Development Sales Market Share by Country/Region (2025)
Figure 8. Artificial Intelligence Drug Development Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Artificial Intelligence Drug Development Market Size Market Share by Type in 2025
Figure 10. Global Artificial Intelligence Drug Development Market Size Market Share by Model Parameter Scale in 2025
Figure 11. Global Artificial Intelligence Drug Development Market Size Market Share by Applicable Drug in 2025
Figure 12. Artificial Intelligence Drug Development in Oncology Therapeutics
Figure 13. Global Artificial Intelligence Drug Development Market: Oncology Therapeutics (2021-2026) & ($ millions)
Figure 14. Artificial Intelligence Drug Development in Infectious Disease Drugs
Figure 15. Global Artificial Intelligence Drug Development Market: Infectious Disease Drugs (2021-2026) & ($ millions)
Figure 16. Artificial Intelligence Drug Development in Neurological Disorder Drugs
Figure 17. Global Artificial Intelligence Drug Development Market: Neurological Disorder Drugs (2021-2026) & ($ millions)
Figure 18. Artificial Intelligence Drug Development in Cardiovascular Disease Drugs
Figure 19. Global Artificial Intelligence Drug Development Market: Cardiovascular Disease Drugs (2021-2026) & ($ millions)
Figure 20. Artificial Intelligence Drug Development in Rare Disease Drugs
Figure 21. Global Artificial Intelligence Drug Development Market: Rare Disease Drugs (2021-2026) & ($ millions)
Figure 22. Artificial Intelligence Drug Development in Autoimmune Disease Drugs
Figure 23. Global Artificial Intelligence Drug Development Market: Autoimmune Disease Drugs (2021-2026) & ($ millions)
Figure 24. Global Artificial Intelligence Drug Development Market Size Market Share by Application in 2025
Figure 25. Global Artificial Intelligence Drug Development Revenue Market Share by Player in 2025
Figure 26. Global Artificial Intelligence Drug Development Market Size Market Share by Region (2021-2026)
Figure 27. Americas Artificial Intelligence Drug Development Market Size 2021-2026 ($ millions)
Figure 28. APAC Artificial Intelligence Drug Development Market Size 2021-2026 ($ millions)
Figure 29. Europe Artificial Intelligence Drug Development Market Size 2021-2026 ($ millions)
Figure 30. Middle East & Africa Artificial Intelligence Drug Development Market Size 2021-2026 ($ millions)
Figure 31. Americas Artificial Intelligence Drug Development Value Market Share by Country in 2025
Figure 32. United States Artificial Intelligence Drug Development Market Size Growth 2021-2026 ($ millions)
Figure 33. Canada Artificial Intelligence Drug Development Market Size Growth 2021-2026 ($ millions)
Figure 34. Mexico Artificial Intelligence Drug Development Market Size Growth 2021-2026 ($ millions)
Figure 35. Brazil Artificial Intelligence Drug Development Market Size Growth 2021-2026 ($ millions)
Figure 36. APAC Artificial Intelligence Drug Development Market Size Market Share by Region in 2025
Figure 37. APAC Artificial Intelligence Drug Development Market Size Market Share by Type (2021-2026)
Figure 38. APAC Artificial Intelligence Drug Development Market Size Market Share by Application (2021-2026)
Figure 39. China Artificial Intelligence Drug Development Market Size Growth 2021-2026 ($ millions)
Figure 40. Japan Artificial Intelligence Drug Development Market Size Growth 2021-2026 ($ millions)
Figure 41. South Korea Artificial Intelligence Drug Development Market Size Growth 2021-2026 ($ millions)
Figure 42. Southeast Asia Artificial Intelligence Drug Development Market Size Growth 2021-2026 ($ millions)
Figure 43. India Artificial Intelligence Drug Development Market Size Growth 2021-2026 ($ millions)
Figure 44. Australia Artificial Intelligence Drug Development Market Size Growth 2021-2026 ($ millions)
Figure 45. Europe Artificial Intelligence Drug Development Market Size Market Share by Country in 2025
Figure 46. Europe Artificial Intelligence Drug Development Market Size Market Share by Type (2021-2026)
Figure 47. Europe Artificial Intelligence Drug Development Market Size Market Share by Application (2021-2026)
Figure 48. Germany Artificial Intelligence Drug Development Market Size Growth 2021-2026 ($ millions)
Figure 49. France Artificial Intelligence Drug Development Market Size Growth 2021-2026 ($ millions)
Figure 50. UK Artificial Intelligence Drug Development Market Size Growth 2021-2026 ($ millions)
Figure 51. Italy Artificial Intelligence Drug Development Market Size Growth 2021-2026 ($ millions)
Figure 52. Russia Artificial Intelligence Drug Development Market Size Growth 2021-2026 ($ millions)
Figure 53. Middle East & Africa Artificial Intelligence Drug Development Market Size Market Share by Region (2021-2026)
Figure 54. Middle East & Africa Artificial Intelligence Drug Development Market Size Market Share by Type (2021-2026)
Figure 55. Middle East & Africa Artificial Intelligence Drug Development Market Size Market Share by Application (2021-2026)
Figure 56. Egypt Artificial Intelligence Drug Development Market Size Growth 2021-2026 ($ millions)
Figure 57. South Africa Artificial Intelligence Drug Development Market Size Growth 2021-2026 ($ millions)
Figure 58. Israel Artificial Intelligence Drug Development Market Size Growth 2021-2026 ($ millions)
Figure 59. Turkey Artificial Intelligence Drug Development Market Size Growth 2021-2026 ($ millions)
Figure 60. GCC Countries Artificial Intelligence Drug Development Market Size Growth 2021-2026 ($ millions)
Figure 61. Americas Artificial Intelligence Drug Development Market Size 2027-2032 ($ millions)
Figure 62. APAC Artificial Intelligence Drug Development Market Size 2027-2032 ($ millions)
Figure 63. Europe Artificial Intelligence Drug Development Market Size 2027-2032 ($ millions)
Figure 64. Middle East & Africa Artificial Intelligence Drug Development Market Size 2027-2032 ($ millions)
Figure 65. United States Artificial Intelligence Drug Development Market Size 2027-2032 ($ millions)
Figure 66. Canada Artificial Intelligence Drug Development Market Size 2027-2032 ($ millions)
Figure 67. Mexico Artificial Intelligence Drug Development Market Size 2027-2032 ($ millions)
Figure 68. Brazil Artificial Intelligence Drug Development Market Size 2027-2032 ($ millions)
Figure 69. China Artificial Intelligence Drug Development Market Size 2027-2032 ($ millions)
Figure 70. Japan Artificial Intelligence Drug Development Market Size 2027-2032 ($ millions)
Figure 71. Korea Artificial Intelligence Drug Development Market Size 2027-2032 ($ millions)
Figure 72. Southeast Asia Artificial Intelligence Drug Development Market Size 2027-2032 ($ millions)
Figure 73. India Artificial Intelligence Drug Development Market Size 2027-2032 ($ millions)
Figure 74. Australia Artificial Intelligence Drug Development Market Size 2027-2032 ($ millions)
Figure 75. Germany Artificial Intelligence Drug Development Market Size 2027-2032 ($ millions)
Figure 76. France Artificial Intelligence Drug Development Market Size 2027-2032 ($ millions)
Figure 77. UK Artificial Intelligence Drug Development Market Size 2027-2032 ($ millions)
Figure 78. Italy Artificial Intelligence Drug Development Market Size 2027-2032 ($ millions)
Figure 79. Russia Artificial Intelligence Drug Development Market Size 2027-2032 ($ millions)
Figure 80. Egypt Artificial Intelligence Drug Development Market Size 2027-2032 ($ millions)
Figure 81. South Africa Artificial Intelligence Drug Development Market Size 2027-2032 ($ millions)
Figure 82. Israel Artificial Intelligence Drug Development Market Size 2027-2032 ($ millions)
Figure 83. Turkey Artificial Intelligence Drug Development Market Size 2027-2032 ($ millions)
Figure 84. Global Artificial Intelligence Drug Development Market Size Market Share Forecast by Type (2027-2032)
Figure 85. Global Artificial Intelligence Drug Development Market Size Market Share Forecast by Application (2027-2032)
Figure 86. GCC Countries Artificial Intelligence Drug Development Market Size 2027-2032 ($ millions)
